Skip to main content
. 2022 Sep 15;13:954653. doi: 10.3389/fimmu.2022.954653

Figure 8.

Figure 8

Screening potential drugs for HCC. Five drugs with great differences in drug sensitivity between two groups: sorafenib (A-B), imatinib (C-D), saracatinib (E-F), bortezomib (G-H) and crizotinib (I-J).